ONHS Report: HT942526ATRPCRA

DoW Arthritis Clinical Research Award

Solicitation ID: HT942526ATRPCRA

Agency: DHA

Type: Grant

Deadline: 2026-10-22T00:00:00 ET

Eligibility: Maybe (Team Member/MIPR)

Funding: Approximately $7.15M is expected to be allotted to fund approximately three Research Level 1 awards (up to $1.30M each) and one Research Level 2 award (up to $3.25M).

Doc Type: BAA

Clearance: No

Program Manager: help@eBRAP.org

Last Updated: 2026-08-19 15:06

Analyzed File: HT942526ATRPCRA_GG.pdf

Eligibility Reasoning

Applications from investigators within the DOW and applications involving multidisciplinary collaborations among academia, industry, the DOW, the U.S. Department of Veterans Affairs (VA) and other federal government agencies are highly encouraged.... Funding obligated to intragovernmental and intramural DOW organizations will be sent through the Military Interdepartmental Purchase Request (MIPR)...

Note: This is an AI-generated summary...

Summary

The Fiscal Year 2026 (FY26) Arthritis Research Program (ATRP) Clinical Research Award (CRA) supports clinical research evaluating disease-specific factors and interventions to generate evidence that can optimize patient outcomes and inform clinical policy for all types of arthritis. Applications must address one of two Focus Areas: 'Prevention and Early Diagnosis' or 'Treatment and Mitigation of Disease Progression/Burden'. The award offers two distinct levels: Research Level 1 for clinical research or early-phase/pilot trials (up to $1.30M), and Research Level 2 for full-scale clinical trials (up to $3.25M), both with a 4-year maximum performance period. Preliminary data is required. A key feature is the emphasis on community collaboration (encouraged for Level 1, mandatory for Level 2) to integrate patient and community perspectives. Projects must also demonstrate relevance to military health. Preclinical research is not supported by this award.

Overall Technical Areas

Arthritis Clinical ResearchClinical Intervention EvaluationDisease Prevention StrategiesEarly Diagnosis MethodsDisease Progression MitigationClinical Trial DesignPredictive Factor AnalysisBiostatistical Planning and AnalysisClinical Data ManagementSex as a Biological Variable AnalysisClinical Outcome MeasurementBiospecimen Collection and AnalysisHealth Disparities Research

Probable LBNL Areas

N/A

Focus Areas

Example Priorities:

Identify factors capable of predicting the onset or progression of disease, and/or identify technologies, solutions, or knowledge products for the prevention of arthritis.

Specific Technical Skills:

Predictive ModelingBiomarker DiscoveryEpidemiologyClinical DiagnosticsData ScienceHealth InformaticsMedical ImagingPublic HealthGenomicsBiostatistics

Potential PIs for this Area:

Name	Score	Organization

Example Priorities:

Evaluate interventions or treatment strategies that address the multifactorial burden of arthritis.
This may include solutions which address one or more of the following factors: pain or other symptoms, function, psychosocial factors, comorbidities, or the pathologic burden of disease.

Specific Technical Skills:

Clinical Trial DesignIntervention ResearchPain ManagementHealth Outcomes ResearchPharmacologyRehabilitation ScienceBehavioral HealthRheumatologyComorbidity ManagementPatient-Reported Outcomes

Potential PIs for this Area:

Name	Score	Organization

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

Name	Score	Organization
Jennifer Rosenbluth	0.73	· Early Diagnosis Methods
Michelle O'Malley	0.71	BSA \| Biological Systems & Engineering \| Biodesign Dept · Disease Progression Mitigation
Likun Zhang	0.71	EESA \| CESD \| Earth System Sciences · Predictive Factor Analysis
Amy Kronenberg	0.70	BSA \| Biological Systems & Engineering \| Biodesign Dept · Sex as a Biological Variable Analysis
Seth Carbon	0.70	BSA \| Env. Genomics & Sys. Biology \| BioSystems Data Science · Clinical Data Management
Li-Wen (Audrey) Wang	0.70	BSA \| Biological Systems & Engineering \| Biodesign Dept · Biospecimen Collection and Analysis
Tamas Torok	0.70	EESA \| CESD \| Molecular Ecology & Biogeochem · Clinical Intervention Evaluation
Stephanie Holm	0.70	ETA \| Energy Analysis \| Systems & Energy Tech Analysis · Disease Prevention Strategies
Eleanor Zizka	0.70	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · Clinical Trial Design
Zixi Hu	0.70	CSA \| AMCR \| Mathematics · Biostatistical Planning and Analysis

Fundamental Research Exemption (FRE)

In accordance with National Security Presidential Memorandum-33 and all associated laws, all fundamental research funded by the DOW must be evaluated for affiliations with foreign entities.